Literature DB >> 11510297

Peritoneal dialysis solutions disturb the balance of apoptosis and proliferation of peritoneal cells in chronic dialysis model.

Z Zheng1, R Ye, X Yu, J Bergström, B Lindholm.   

Abstract

The present study investigated variation in apoptosis and proliferation, and the balance between apoptosis and proliferation, for peritoneal mesothelial cells (MCs) after exposure to peritoneal dialysis solution (PDS) in vivo. We implanted 32 male Sprague-Dawley rats (4 groups; n = 8 in each group) with catheters and intraperitoneally infused the animals with 20 mL Dianeal 1.36%, 2.27%, or 3.86% (Baxter Healthcare Corporation, Deerfield, IL, U.S.A.) PDS twice daily for eight consecutive weeks, using saline as a control. At the end of the eighth week, samples of peritoneal membrane were fixed and sliced. Expression of apoptosis was checked with TUNEL kits (Boehringer Mannheim, Mannheim, Germany), and expression of proliferative cell nuclear antigen (PCNA) was checked by immunohistochemistry [streptoavidin-biotin-peroxidase complex (SABC) method]. The ratio of MC apoptosis to proliferation was measured from the same slices using the dual-stain combination of TUNEL and SABC. Cells positive for apoptosis and PCNA were counted for all samples by light microscopy in 50 consecutive grids (10 x by 40). Peritoneal dialysis solution was found to significantly induce MC apoptosis as compared with control at the end of the eighth week. The degree of apoptosis was proportional to the concentration of glucose in the PDS. The 1.36% PDS, but not the 2.27% or 3.86%, significantly stimulated the expression of PCNA. The degree of PCNA expression was negatively related to the glucose concentration of the PDS. The MC apoptosis: PCNA ratio was significantly higher for 3.86% and 2.27% PDS than for the control, but no significant difference was seen between 1.36% PDS and control. We conclude that glucose-based PDS may induce apoptosis and disturb the balance of MC apoptosis and proliferation, and that 1.36% PDS damages the balance less than does 2.27% or 3.86% PDS. These effects may be partly due to pH, calcium, hyperosmolality, and glucose degradation products (GDPs). Loss of balance between MC proliferation and apoptosis--induced by unphysiologic PDS--may be one of the major causes of peritoneal membrane failure during long-term continuous ambulatory peritoneal dialysis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11510297

Source DB:  PubMed          Journal:  Adv Perit Dial        ISSN: 1197-8554


  6 in total

1.  Role of IGF-1R in epithelial-mesenchymal transdifferentiation of human peritoneal mesothelial cells.

Authors:  Yangyang Xia; Cheng Wan; Qingyan Zhang; Hengjin Wang; Yuan Feng; Chunming Jiang
Journal:  Clin Exp Nephrol       Date:  2022-03-24       Impact factor: 2.801

2.  Conventional versus biocompatible peritoneal dialysis fluids: more questions than answers?

Authors:  Karima Farhat; Frans Jan van Ittersum; Piet Marten Ter Wee; Caroline Ellen Douma
Journal:  NDT Plus       Date:  2008-10

3.  Is there different risk of cancer among end-stage renal disease patients undergoing hemodialysis and peritoneal dialysis?

Authors:  Yi-Che Lee; Shih-Yuan Hung; Hao-Kuang Wang; Chi-Wei Lin; Hsi-Hao Wang; Min-Yu Chang; Junne-Ming Sung; Yuan-Yow Chiou; Sheng-Hsiang Lin
Journal:  Cancer Med       Date:  2018-01-22       Impact factor: 4.452

4.  Vitamin D can ameliorate chlorhexidine gluconate-induced peritoneal fibrosis and functional deterioration through the inhibition of epithelial-to-mesenchymal transition of mesothelial cells.

Authors:  Yi-Che Lee; Shih-Yuan Hung; Hung-Hsiang Liou; Tsun-Mei Lin; Chu-Hung Tsai; Sheng-Hsiang Lin; Yau-Sheng Tsai; Min-Yu Chang; Hsi-Hao Wang; Li-Chun Ho; Yi-Ting Chen; Ching-Fang Wu; Ho-Ching Chen; Hsin-Pao Chen; Kuang-Wen Liu; Chih-I Chen; Kuan Min She; Hao-Kuang Wang; Chi-Wei Lin; Yuan-Yow Chiou
Journal:  Biomed Res Int       Date:  2015-10-01       Impact factor: 3.411

5.  Autophagy promotes fibrosis and apoptosis in the peritoneum during long-term peritoneal dialysis.

Authors:  Jingjing Wu; Changying Xing; Li Zhang; Huijuan Mao; Xuguan Chen; Mingxing Liang; Fang Wang; Haibin Ren; Hongqing Cui; Aiqin Jiang; Zibin Wang; Meijuan Zou; Yong Ji
Journal:  J Cell Mol Med       Date:  2017-10-27       Impact factor: 5.310

6.  The Clinical Implication of Vitamin D Nanomedicine for Peritoneal Dialysis-Related Peritoneal Damage.

Authors:  Yi-Che Lee; Chih-Ting Huang; Fong-Yu Cheng; Shih-Yuan Hung; Tsun-Mei Lin; Yen-Chang Tsai; Chih-I Chen; Hao-Kuang Wang; Chi-Wei Lin; Hung-Hsiang Liou; Min-Yu Chang; Hsi-Hao Wang; Yuan-Yow Chiou
Journal:  Int J Nanomedicine       Date:  2019-12-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.